High Percentage Of Vigilance Reports Lead To EU Action: Ireland Reflects On 2014
This article was originally published in Clinica
Executive Summary
A total of 64% of the 2,113 medical device Vigilance reports received by the Irish Health Products Regulatory Agency (HPRA) during 2014 resulted in action being taken in Europe. These data have been made public in the HPRA (formerly the Irish Medicines Board) annual report for 2014.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.